Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-20

Clinical Trial Update: Reduction of Bladder Injection Pain With Belladonna Opiate Suppository [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing reduction of bladder injection pain with Belladonna opiate suppository in overactive bladder and related conditions, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belladonna opiate suppository (belladonna opiate suppository)

Snippet

Sponsor: Edgar LeClaire, MD | Conditions: Overactive Bladder, Urinary Urge Incontinence | Phase 4 | Status: COMPLETED | Results posted: 2018-09-20